Press release
Key Trend Reshaping the Liver Diseases Therapeutics Market in 2025: Strategic Partnerships Transforming The Landscape Of Liver Disease Therapeutics
Liver Diseases Therapeutics Market Size
The growth of the liver disease therapeutics market is anticipated to be fueled by the increasing incidence of liver ailments. Therapies for liver disease, which refers to any disorder affecting the liver, aid in the treatment of these diseases through a variety of treatments. For example, the Office for Health Improvement and Disparities, a government agency based in the UK, reported in April 2024 that in 2022, the death rate from liver disease in individuals aged under 75 in England increased to 21.4 per 100,000 population. Notably, there were 6,664 premature deaths among men compared to 3,929 in women. The escalating occurrence of liver diseases is therefore propelling the growth of the liver disease therapeutics market.
Get Your Liver Diseases Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
What is the projected compound annual growth rate (CAGR) of the liver diseases therapeutics market from 2025 to 2034, and what factors influence it?
The market size for therapeutics in liver diseases has witnessed significant growth over the recent years. It is projected to increase from $14.16 billion in 2024 to $15.23 billion in 2025, at a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this growth during the historical period include the high incidence of liver diseases, patterns of alcohol consumption, advances in diagnostic techniques, obesity and metabolic syndrome, awareness campaigns, and screening programs, as well as government efforts to control hepatitis.
Expectations forecast robust expansion in the liver diseases therapeutics market size in the ensuing years. Projected growth is pegged at $20.78 billion by 2029, with a compound annual growth rate (CAGR) of 8.1%. The anticipated growth during this period is attributed to factors like precision medicine methods, advances in RNA therapeutics, emphasis on fibrosis treatments, patient advocacy, support groups, development of hepatitis vaccines, and regulatory support for rare drugs. The forecast period will witness key trends such as advancements in hepatitis c treatment, the emergence of new therapies for liver fibrosis, exploration of immunotherapies, application of telemedicine and remote monitoring, and a focus on nutritional interventions.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7969&type=smp
How are the latest trends influencing the growth of the liver diseases therapeutics market?
The increasing emergence of strategic alliances is a vital trend in the liver disease therapeutics market. Key businesses are forging collaborations in this market to bolster their standing. For example, Aligos Therapeutics Inc., a clinical-stage biopharmaceutical company based in the US, entered into a partnership with Merck & Co, a US company also operating in the liver disease therapeutics space, in January 2022. The focus of this partnership is on the discovery and development of oligonucleotide treatments for non-alcoholic steatohepatitis.
What are the major segments of the liver diseases therapeutics market and their role in driving growth?
The liver diseases therapeutics market covered in this report is segmented -
1) By Disease Type: Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer
2) By Treatment: Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users
Subsegments:
1) By Hepatitis: Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D
2) By Non-Alcoholic Fatty Liver Disease (NAFLD): Non-Alcoholic Steatohepatitis (NASH), Simple Fatty Liver
3) By Alcohol-Induced Liver Disease: Alcoholic Hepatitis, Alcoholic Cirrhosis
4) By Liver Cancer: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7969
Which regions are key players in the growth of the liver diseases therapeutics market?
North America was the largest region in the liver diseases therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the liver diseases therapeutics market report during the forecast period. The regions covered in the liver diseases therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the liver diseases therapeutics market?
Major companies operating in the liver diseases therapeutics market are Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline PLC, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., Takeda Pharmaceutical Company Limited, Valeant Pharmaceuticals, Watson Pharmaceuticals Inc., AstraZeneca PLC, Gilead Sciences Inc., Endo International PLC, Alnylam Pharmaceuticals Inc., Provectus Biopharmaceuticals Inc., Intercept Pharmaceuticals Inc., Conatus Pharmaceuticals Inc., CymaBay Therapeutics Inc., Viking Therapeutics Inc., Madrigal Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Enanta Pharmaceuticals Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7969&type=smp
What Is Covered In The Liver Diseases Therapeutics Global Market Report?
• Market Size Forecast: Examine the liver diseases therapeutics market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the liver diseases therapeutics market for a structured understanding.
• Key Players Overview: Analyze major players in the liver diseases therapeutics market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the liver diseases therapeutics market.
• Segment Contributions: Evaluate how different segments drive overall growth in the liver diseases therapeutics market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the liver diseases therapeutics market.
• Industry Challenges: Identify potential risks and obstacles affecting the liver diseases therapeutics market.
• Competitive Landscape: Review strategic developments in the liver diseases therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trend Reshaping the Liver Diseases Therapeutics Market in 2025: Strategic Partnerships Transforming The Landscape Of Liver Disease Therapeutics here
News-ID: 3888275 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Liver
Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Dri …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Liver Metastases Treatment Market Size By 2025?
The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of…
LivCare Liver Support
The liver plays a crucial role in maintaining overall well-being, performing essential functions like detoxification, digestion, and metabolism. However, many people overlook the importance of liver health until problems arise. LivCare Liver Support is a premium supplement designed to keep your liver in peak condition. By incorporating this supplement into your daily routine, you can help ensure your liver functions optimally, leading to better overall health.
● Product Name - LivCare…
Liver Cancer Therapeutics Market - Empowering Recovery, Restoring Health: Innova …
Newark, New Castle, USA - new report, titled Liver Cancer Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Liver Cancer Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Liver Cancer Therapeutics market. The report offers an overview of…
Liver Health Supplements Market Grows Strong as Consumers Adopt Proactive Measur …
Global liver health supplements market was valued at US$ 8.7 Bn in 2021, is growing at an estimated CAGR of 5.8% over the forecast period (2022 - 2030). The liver health supplements market is growing due to the increasing awareness of the importance of liver health and the rise of lifestyle-related liver diseases. The market offers a wide range of supplements that help in improving liver function, supporting liver detoxification,…
Urgent Liver 911 Reviews 2021: Is Urgent Liver 911 Legit?
Urgent Liver 911 by PhytAge Laboratories is a powerful diet that promotes liver function by combining natural minerals and nutrients. The diet is made up of plant and herbal extracts that collectively aid in liver cell protection. While the liver is an important human organ that promotes general health and vitality, most people are unaware that even those who appear to be in good health can be affected by liver…
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production…
